Buscador de publicacions

Publicacions

  • Stricker T, Morales-La Madrid A, Chlenski A, Guerrero L, Salwen, Helen R., Gosiengfiao Y, Perlman E, Furman W, Bahrami A, Shohet, Jason M., Zage P, Hicks J, Shimada, Hiroyuki, Suganuma R, Park J, So S, London W, Pytel P, Maclean K and Cohn S.

    Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter (TM) system

    MOLECULAR ONCOLOGY . 8(3): 669-678. Nº de cites: 26

    [doi:10.1016/j.molonc.2014.01.010]

  • Morales-La Madrid A, Santa-María V, Cruz-Martínez O, Mora J, Puerta Roldan P, Guillen-Quesada A, Suñol M, de Torres C, Lassaletta A, Laperriere N, Villà S and Bouffet E.

    Second re-irradiation for DIPG progression, re-considering "old strategies" with new approaches

    CHILDS NERVOUS SYSTEM . 33(5): 849-852. Nº de cites: 8

    [doi:10.1007/s00381-017-3352-y]

  • Janssens GO, Gandola L, Bolle S, Mandeville H, Ramos-Albiac M, van Beek K, Benghiat H, Hoeben B, Morales-La Madrid A, Kortmann RD, Hargrave D, Menten J, Pecori E, Biassoni V, von Bueren AO, van Vuurden DG, Massimino M, Sturm D, Peters M and Kramm CM.

    Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group

    EUROPEAN JOURNAL OF CANCER . 73: 38-47. Nº de cites: 38

    [doi:10.1016/j.ejca.2016.12.007]

  • Greenfield JP, Castañeda A, George E, Kieran MW and Morales-La Madrid A.

    Gliomatosis cerebri: A consensus summary report from the First International Gliomatosis cerebri Group Meeting, March 26-27, 2015, Paris, France

    PEDIATRIC BLOOD & CANCER . 63(12): 2072-2077. Nº de cites: 12

    [doi:10.1002/pbc.26169]

  • Zacharoulis S, Morales-La Madrid A, Bandopadhayay P, Chi SN, Manley P, Ullrich NN, Marcus K, Goumnerova L, Scott RM, Proctor M, Young-Poussaint T, De Girolami U and Kieran MW.

    Central Versus Extraventricular Neurocytoma in Children: A Clinicopathologic Comparison and Review of the Literature

    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY . 38(6): 479-485. Nº de cites: 3

    [doi:10.1097/MPH.0000000000000627]

  • Veldhuijzen van Zanten SE, van Meerwijk CL, Jansen MH, Twisk JW, Anderson AK, Coombes L, Breen M, Hargrave OJ, Hemsley J, Craig F, Cruz-Martínez O, Kaspers GJ, van Vuurden DG, Hargrave DR and SIOPE DIPG Network.

    Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey

    Neuro-Oncology . 18(4): 582-588. Nº de cites: 13

    [doi:10.1093/neuonc/nov250]

  • Morales-La Madrid A, Hashizume R and Kieran MW.

    Future clinical trials in DIPG: bringing epigenetics to the clinic

    Frontiers in oncology . 5: 148-148. Nº de cites: 29

    [doi:10.3389/fonc.2015.00148]

  • Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales-La Madrid A, Marcus KJ, Guo D, Ullrich NJ, Robison NJ, Chi SN, Beroukhim R, Kieran MW and Manley PE.

    Long-Term Outcome of 4,040 Children Diagnosed With Pediatric Low-Grade Gliomas: An Analysis of the Surveillance Epidemiology and End Results (SEER) Database

    PEDIATRIC BLOOD & CANCER . 61(7): 1173-1179. Nº de cites: 117

    [doi:10.1002/pbc.24935]

  • Morales-La Madrid A, Campbell N, Smith S, Cohn S and Salgia R.

    Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma (vol 7, pg 199, 2012)

    TARGETED ONCOLOGY . 8(4): 301-301.

    [doi:10.1007/s11523-013-0291-8]

  • Morales-La Madrid A.

    Life changes us

    PEDIATRIC BLOOD & CANCER . 64(10): e26608.

    [doi:10.1002/pbc.26608]